Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vistart Global is a medical technology company specializing in innovative vascular access solutions for patients with end-stage renal disease (ESRD). The company's primary focus is the development and commercialization of the Vistart system, a novel device designed to improve the efficiency and safety of hemodialysis access. By addressing the critical challenges associated with traditional vascular access methods, Vistart Global aims to reduce complications and improve long-term outcomes for dialysis patients. The company was founded by Dr. John B. Simpson, a renowned pioneer in the field of interventional cardiology and medical device innovation. Headquartered in Irvine, California, Vistart Global leverages advanced engineering to streamline clinical workflows in renal care settings. The Vistart system represents a significant advancement in the standardization of vascular access procedures, potentially lowering the overall cost of care for healthcare providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vistart Global.